| Time and Virtual Reality in Schizophrenia and Bipolar Disorder (NCT04432116) | Institut National de la Santé Et de la Recherche Médicale, France | 2021-08-12 |
| Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients (NCT04929795) | Dr WANG Shumei | 2021-08-11 |
| CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia (NCT04860830) | Boehringer Ingelheim | 2021-08-09 |
| Schizophrenia Treatment With Photoneuromodulation (NCT05339347) | University of Sao Paulo | 2021-08-01 |
| Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia (NCT05835583) | National Taipei University of Nursing and Health Sciences | 2021-08-01 |
| A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings (NCT04940039) | Janssen-Cilag International NV | 2021-07-22 |
| Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia (NCT04681807) | The Royal Ottawa Mental Health Centre | 2021-07-21 |
| Cigarette Smoking in Smokers With and Without Schizophrenia (NCT04001114) | University of Maryland, Baltimore | 2021-07-15 |
| Lumateperone for the Prevention of Relapse in Patients With Schizophrenia (NCT04959032) | Intra-Cellular Therapies, Inc. | 2021-07-08 |
| Memantine Augmentation of Targeted Cognitive Training in Schizophrenia (NCT04857983) | University of California, San Diego | 2021-07-06 |
| Virtual Reality Avatar Therapy for People Hearing Voices (NCT04099940) | Psychiatric University Hospital, Zurich | 2021-07-01 |
| eMove - Dance/Movement Therapy Study (NCT05712928) | Drexel University | 2021-06-29 |
| Dimensional and Developmental Profiles of Psychosis in Children and Adolescents (NCT04370730) | Assistance Publique - Hôpitaux de Paris | 2021-06-02 |
| eMotiph: E-mental Health Solution for Patients With Schizophrenia (NCT05345977) | Grupo Pulso | 2021-06-01 |
| PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing (NCT04787302) | Cerevel Therapeutics, LLC | 2021-06-01 |
| Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia (NCT05278156) | Celon Pharma SA | 2021-05-19 |
| A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. (NCT04865835) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2021-05-12 |
| Feasibility of a Novel Process-based Treatment for Patients With Psychosis (NCT04874974) | Max-Planck-Institute of Psychiatry | 2021-05-10 |
| The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis (NCT04916626) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2021-05-06 |
| tDCS and Executive Function Training for Schizophrenia (NCT05389345) | University of Toronto | 2021-05-01 |
| Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building (NCT04446234) | Shanghai Mental Health Center | 2021-05-01 |
| Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia (NCT04822883) | Recognify Life Sciences | 2021-04-26 |
| M1 Schizophrenia PET Study (NCT05105542) | Yale University | 2021-04-20 |
| rTMS on Appetite and Cognitive Function in Schizophrenia (NCT04714970) | Central South University | 2021-04-20 |
| Baduanjin on Patients With Schizophrenia (NCT04430309) | Chang Gung Memorial Hospital | 2021-04-10 |
| Insomnia in the Patient With Schizophrenic Disorder: Evaluation of a CBT and Psychoeducational Intervention (NCT05115604) | David Batalla-Martin | 2021-04-08 |
| A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) (NCT04738123) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2021-04-06 |
| Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia (NCT05342727) | The National Brain Mapping Laboratory (NBML) | 2021-04-01 |
| Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (NCT04418466) | Delpor, Inc. | 2021-04-01 |
| Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia (NCT04859504) | Shanghai Mental Health Center | 2021-04-01 |
| The Effect of Psychoeducation Program on Healthy Living Behaviors (NCT05208021) | Saglik Bilimleri Universitesi | 2021-03-29 |
| Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders (NCT04783285) | CEDIARA - Assoc. Solidariedade Social de Ribeira de Fráguas | 2021-03-29 |
| The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center (NCT05109572) | Dr. Lutfi Kirdar Kartal Training and Research Hospital | 2021-03-20 |
| Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness (NCT04118283) | VA Office of Research and Development | 2021-03-18 |
| Ketogenic Diet for Psychotic Disorders (NCT03873922) | Kuopio University Hospital | 2021-03-15 |
| Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder (NCT04779177) | Intra-Cellular Therapies, Inc. | 2021-03-12 |
| Comparative Bioavailability of Risperidone. (NCT05179525) | Rovi Pharmaceuticals Laboratories | 2021-03-09 |
| A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects (NCT04839926) | Jiangsu Nhwa Pharmaceutical Co., Ltd. | 2021-03-02 |
| Peripheral Immune System in Individuals With Schizophrenia (NCT05109065) | Stanford University | 2021-03-01 |
| Biomarkers in Clozapine-responding Schizophrenia (NCT05316883) | Jimmi Nielsen | 2021-02-28 |
| Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia (NCT04761861) | Sadat City University | 2021-02-16 |
| Virtual Cognitive Behavioural Therapy for Psychosis (NCT04752449) | University of Toronto | 2021-02-01 |
| An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) (NCT04659174) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2021-02-01 |
| Peer-delivered and Technology-Assisted Integrated Illness Management and Recovery (NCT04481737) | Dartmouth-Hitchcock Medical Center | 2021-02-01 |
| Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder (NCT04578756) | AbbVie | 2021-02-01 |
| VLT-015 in Patients With Schizophrenia (NCT05516121) | CF Pharma, LLC | 2021-02-01 |
| Effectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic Disorder (NCT04911010) | University of Hamburg-Eppendorf | 2021-01-20 |
| Horyzons: Implementation in Clinical Practice (NCT04673851) | University of North Carolina, Chapel Hill | 2021-01-19 |
| Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18 (NCT04849026) | Whanin Pharmaceutical Company | 2021-01-15 |
| A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia (NCT04712734) | Vanda Pharmaceuticals | 2021-01-13 |
| Relative Bioavailability of LY03010 Compared to Listed Drug (NCT04922593) | Luye Pharma Group Ltd. | 2021-01-13 |
| Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy (NCT05140135) | University of Pennsylvania | 2021-01-11 |
| Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers (NCT04588129) | LB Pharmaceuticals Inc. | 2021-01-05 |
| Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement (NCT04602741) | Centre for Addiction and Mental Health | 2021-01-04 |
| Group Cognitive Behavioural Family Intervention (CBFI) for People With Schizophrenia and Their Families (NCT04065360) | Hospital Authority, Hong Kong | 2021-01-01 |
| Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study (NCT04605393) | King's College London | 2021-01-01 |
| Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia (NCT04709224) | Intra-Cellular Therapies, Inc. | 2020-12-30 |
| A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study. (NCT04742413) | Angelini Farmacéutica | 2020-12-29 |
| A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) (NCT04659161) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2020-12-16 |
| Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008) (NCT04624243) | Merck Sharp & Dohme LLC | 2020-12-15 |
| Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing (NCT04554121) | Columbia University | 2020-12-14 |
| Peer-led Psycho-education for Schizophrenia (NCT03246932) | Chinese University of Hong Kong | 2020-12-01 |
| Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations (NCT04399096) | University of Cambridge | 2020-12-01 |
| Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders (NCT04221269) | Butler Hospital | 2020-12-01 |
| Optimizing Cognitive Remediation (NCT04395157) | VA Office of Research and Development | 2020-12-01 |
| Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia (NCT04959201) | China Medical University Hospital | 2020-11-30 |
| Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders (NCT04418011) | Centre for Addiction and Mental Health | 2020-11-30 |
| In-person vs. Remote Wellness Support (NCT04526067) | The University of Texas Health Science Center at San Antonio | 2020-11-24 |
| Medial-prefrontal Enhancement During Schizophrenia Systems Imaging (NCT04807530) | University of California, San Francisco | 2020-11-12 |
| Neuroplasticity in TBI and Schizophrenia (NCT03995368) | VA Office of Research and Development | 2020-11-09 |
| Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia (NCT04414930) | University of California, San Diego | 2020-11-09 |
| Improving Physical Health in Patients With Psychiatric Disorders in General Practice (SOFIA) (NCT04618250) | University of Copenhagen | 2020-11-06 |
| Self-Determination Theory and Motivational Interviewing (NCT04611737) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2020-11-03 |
| Song-making In a Group (SING) R61 (NCT05537428) | Yale University | 2020-10-31 |
| A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia (NCT04510298) | Sirtsei Pharmaceuticals, Inc. | 2020-10-15 |
| Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia (NCT04917302) | China Medical University Hospital | 2020-10-13 |
| Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder (NCT04278339) | Centre Hospitalier Universitaire de Nice | 2020-10-10 |
| Diagnostic Announcement to Relatives of Patients With Schizophrenia (NCT04562961) | University Hospital, Grenoble | 2020-10-10 |
| Using mHealth to Optimize Pharmacotherapy Regimens (NCT04248517) | New York State Psychiatric Institute | 2020-10-09 |
| Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs (NCT04590300) | Centre Hospitalier Charles Perrens, Bordeaux | 2020-10-06 |
| Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning (NCT04520399) | Shanghai Mental Health Center | 2020-10-01 |
| RELATE - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations (NCT04578314) | University of Hamburg-Eppendorf | 2020-10-01 |
| Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis (NCT05571228) | Queen's University | 2020-10-01 |
| Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome (NCT04518319) | Shanghai Mental Health Center | 2020-10-01 |
| Families With Substance Use and Psychosis: A Pilot Study (NCT04284813) | Mclean Hospital | 2020-09-24 |
| ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention (NCT04298450) | Centre for Addiction and Mental Health | 2020-09-21 |
| Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control (NCT04941677) | National Cheng-Kung University Hospital | 2020-09-17 |
| Efficacy of Chronic Disease Self-management Program in People With Schizophrenia (NCT04503954) | National Taipei University of Nursing and Health Sciences | 2020-09-07 |
| Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia (NCT04481217) | University Hospital, Grenoble | 2020-09-04 |
| Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia (NCT05282329) | Tianjin Anding Hospital | 2020-09-01 |
| A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients (NCT04521868) | Central South University | 2020-08-31 |
| Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients (NCT04553835) | Dr WANG Shumei | 2020-08-31 |
| Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia (NCT03818516) | Emory University | 2020-08-31 |
| Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011) (NCT04506905) | Merck Sharp & Dohme LLC | 2020-08-28 |
| Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment (NCT04421456) | Jazz Pharmaceuticals | 2020-08-18 |
| Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (NCT04531982) | ACADIA Pharmaceuticals Inc. | 2020-08-05 |
| Animal-Assisted Therapy in Patients With Schizophrenia (NCT04476836) | Chang Gung Memorial Hospital | 2020-08-01 |
| Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia (NCT03911726) | Central Institute of Mental Health, Mannheim | 2020-08-01 |
| Efficacy of Transcranial Direct Current Stimulation in Treatment of Cognitive Deficits in Early Stages of Psychosis (NCT03071484) | Instituto Bairral de Psiquiatria | 2020-08-01 |
| Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia (NCT05304780) | National Taipei University of Nursing and Health Sciences | 2020-07-15 |